This site did not show evidence of storing passwords in plaintext.
This site does allow secured connections (https)
This site did show a clear way to unsubscribe from their emails
This site does verify your email address.
Membership Emails
Below is a sample of the emails you can expect to receive when signed up to eye tube.
Don't miss an Eyewire TV! Add us to your address book: EyeWireMail@bmcenews.com
NEW EPISODE | May 27, 2020
WATCH THIS WEEK'S EPISODE
IN THIS EPISODE
BMC Virtual Spring Symposium to Take Place This Weekend
Mass. Eye and Ear Develops Novel Gene-Based COVID-19 Vaccine Candidate
Port Delivery System With Ranibizumab Shows Positive Phase 3 Results in Wet AMD
VIEW ALL SEGMENTS
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to EyewireTV Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Join us for timely insights from 4 leaders in scleral lenses.
Learn more about these timely topics relating to the future of your practice in this 45 minute virtual meeting:
Reopening your practice
Patient safety - what is the new normal?
The future of scleral lens fitting
How new technologies have influenced scleral lens fitting
Includes live Q&A from around the world. Don't miss this live on demand learning opportunity
This live, interactive panel discussion features:
Thomas P. Arnold, OD, FSLS
Melissa Barnett, OD, FAAO, FSLS, FBCLA
Daddi Fadel, Dip Optom, FSLS
Christine Sindt, OD, FAAO, FSLS
CLICK HERE TO REGISTER FOR FREE
Join us for ICSC 2021 in Fort Lauderdale
July 23 - 24, 2021 | W Hotel Fort Lauderdale
Expect to learn about scleral lens topics such as upcoming scleral technologies, side effects of sclerals, solutions for fogging, toric peripheral curves, marketing your practice, ocular surface disease, and much more.
Learn More
View email in your browser
This sponsored message helps support the free educational content produced by Bryn Mawr Communications LLC.
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania19087 | United States
You received this email because you are subscribed to BMC Group from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
What is the 5-year success rate of a corneal transplant?
The short answer? 76%.
A new study published in the Canadian Journal of Ophthalmology examined 596 patients who had primary penetrating keratoplasty between 2011 and 2017. The authors found the 3-year survival rate was 78%. At 5 years, the survival rate was 76%, and at 7 years it was 73%.
Is this different from what was previously published?
Yes. Previous studies that the success rates were higher, around 90% at 5 years.
In other news:
Floating the idea of same-day bilateral cataract surgeries?
In an editorial published in Ophthalmology, the authors suggest that the time for bilateral same-day cataract surgery is now.
Advertisement:
WHAT YOUR PATIENT MIGHT ASK YOU
Can glasses protect me from COVID? A recent study published in JAMA Ophthalmology found that glasses wearers may be less likely to be infected with COVID-19.
Tell me about the study.
The study examined 276 patients in Suizhou, China, who were hospitalized due to COVID-19. Of these patients, 30 wore glasses (16 were myopic and 14 were presbyopic). The 16 myopic patients with COVID-19 who wore their glasses for more than 8 hours per day accounted for 5.8% of patients in the study.
Why is this significant?
One of the main findings of this study was that patients with COVID-19 who wear glasses for more than 8 hours per day were relatively uncommon, representing only 5.8% of patients. The authors associated this with less susceptibility to COVID-19 infection.
Why do they think wearing glasses helps?
There are a couple of theories:
1. Wearing glasses prevents or discourages wearers from touching their eyes, thus avoiding transferring the virus from the hands to the eyes.
2. An abundance of the SARS-CoV-2 receptor angiotensin-converting enzyme 2 has been found on the ocular surface through which SARS-CoV-2 can enter the body. Wearing glasses may become a protective factor, reducing the risk of virus transfer to the eyes.
Why might my patient ask me about this?
Because this study made its way into mainstream media (here, here, here, and here, to name a few sources).
Should we recommend that everyone wear glasses?
Not yet. In fact, an infectious disease specialist at Johns Hopkins School of Medicine wrote a commentary on this study discussing some of its flaws.
SOCIAL MEDIA ROUNDUP
40.9
The percentage of US adults who have skipped medical care since COVID. (via)
The death of one brand of smart glasses inevitably means the birth of another.
Facebook and EssilorLuxottica announced their collaboration on a new generation of smart glasses. The first product will be branded Ray-Ban and is scheduled to launch in 2021. This news comes after VSP discontinued the production of their Level smart glasses. (via)
Looking for a new podcast?
Check out GlobalEyes! Drs. Tom Arnold and Melissa Barnett will be chatting with eye care practitioners from around the world and exploring the state of eye care in their home countries.
Thinking outside the box.
Lumenis is launching a traveling outdoor trade show. (via)
Enjoy this email? Tell your friends to sign up here!
Have news or a comment to share?
send me an email!
Copyright ? 2020 2020glance.com, All rights reserved.
Email Me
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to 20/20 Glance Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Celebrate progress and recognize the challenges.
NEW ISSUE | MAY 2020
The latest issue of CRST celebrates progress toward gender equity in ophthalmology and considers the challenges that remain.
READ MAY ISSUE
THE TOP THREE ARTICLES YOU SHOULD BE READING:
1
The Gender Gap By Lisa Brothers Arbisser, MD; Ashley Brissette, MD, MSc, FRCSC; Sumitra S. Khandelwal, MD; Cynthia Matossian, MD, FACS; Cathleen M. McCabe, MD; Marguerite B. McDonald, MD, FACS; M. Amir Moarefi, MD; Lisa M. Nijm, MD, JD; Karolinne Maia Rocha, MD, PhD; Arsham Sheybani, MD; Denise M. Visco, MD, MBA; O. Bennett Walton IV, MD, MBA; George O. Waring IV, MD, FACS; and Blake K. Williamson, MD, MPH, MS
Get candid insight into how the gender gap has shrunk in ophthalmology and hear from both genders how to influence further advances.
2
COVID-19: An Ageless, Borderless Battle By Sila Bal, MD, MPH
Find out what the pandemic has taught one ophthalmology resident about grit.
3
Cases That Have Stuck With Me By Uday Devgan, MD; Mark Kontos, MD; Mark Lobanoff, MD; Michael E. Snyder, MD; and Elizabeth Yeu, MD
Five ophthalmologists share memorable cases. What did they learn from those experiences?
Also in This Issue
Graftless Corneal Endothelial Replacement ?
How to Optimize Your Practice for Private Equity Purchase ?
Small Pupil, Dense Lens, Severe Zonulopathy ?
READ MAY ISSUE ?
FEATURED VIDEO IN CORNEA
DSAEK for Decompensated Penetrating Graft and ICE Syndrome
By Ozana Moraru, MD
WATCH NOW ON EYETUBE.NET
CATARACT & REFRACTIVE NEWS
05.11.20 Analysis: Ophthalmology Lost More Patient Volume Due to COVID-19 Than Any Other SpecialtyREAD MORE
05.11.20 Scientists Find Eye Cells Are a Prime Target for COVID-19 to Attach toREAD MORE
05.11.20 Oyster Point Announces Results of Phase 3 Trial of OC-01 Nasal Spray for Treatment of Signs and Symptoms of Dry Eye DiseaseREAD MORE
RECENT CATARACT & REFRACTIVE SURGERY Today ISSUES
stay updated on all things Cataract
click here
Advertise | Submit Breaking News | Contact Us
* Free print subscriptions are available to practicing physicians in the US.
All others, applicable subscription charges apply.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
You received this email because you are subscribed to Cataract & Refractive Surgery Today Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us | Legal Disclaimer
Are outcomes successful?
Editorially independent content supported with advertising.
Outcomes With EDOF IOLs After Laser Refractive Surgery
Richard S. Davidson, MD, joins Neda Shamie, MD, to discuss a retrospective review that compared the visual outcomes of extended depth of focus (EDOF) IOLs in eyes with and without a history of laser refractive surgery. Are these IOLs an appropriate choice after LASIK and PRK?
CLICK HERE TO WATCH THE VIDEO
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to Clinical Minute from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
FEATURED NEWS STORY Survey: Use of Virtual Education Soars; Telemedicine Remains a Small Percentage of Volume
Since the onset of the COVID-19 pandemic, the majority of ophthalmologists and optometrists are 'very likely' to participate in virtual education programs, while the percentage of those using telemedicine remains low compared to traditional care. That according to a recent survey conducted by Bryn Mawr Communications (BMC). The survey, which had 229 respondents, was conducted via email and social media in June. VIEW STORY ?
OTHER COVID-19 NEWS 06.23.20
Gilead Looking to Test Easier-To-Use, Inhaled Version of Remdesivir
Gilead Sciences said Monday that it hopes to begin clinical trials this summer evaluating an inhaled formulation of remdesivir, administered via a nebuliser, to patients with COVID-19. The experimental antiviral, which the FDA authorized for emergency use in early May, is currently given intravenously through daily infusions to COVID-19 patients in hospital. VIEW STORY ?
06.23.20 How Regeneron's COVID-19 Antibody Cocktail Cuts the Risk of Resistance
When Regeneron said in March that it would speed an antibody treatment into clinical trials for COVID-19, its scientists insisted a cocktail of two antibodies would be more effective than one alone. Now they're explaining why they chose the two antibodies that moved into human trials last week. VIEW STORY ?
VIEW ALL COVID-19 COVERAGE
This resource has been made possible with support from our industry sponsors
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire News COVID-19 from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
TOP STORY OF THE WEEK The Lancet Withdraws Major Hydroxychloroquine Study
?
TRENDING NEWS 06.04.20
SightGlass Vision Granted CE Mark for Eyeglasses That Slow Myopia Progression in Children
?
06.04.20
BVI Launches CryoTreq for Treatment of Retinal Tears and Detachments
?
06.04.20
Bausch + Lomb Receives FDA Clearance for Infuse Daily Disposable Silicone Hydrogel Contact Lenses
?
06.04.20 Aldeyra Therapeutics Reaches Agreement With FDA for Use of RASP as Dry Eye Disease Sign
?
06.02.20 Nicox Initiates First Phase 3 Trial of NCX 470 in Glaucoma
?
06.01.20
Ocugen to Discontinue Phase 3 oGVHD Trial
?
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire Today Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don't miss the top videos of the month on Eyetube.net!
What''s New to Eyetube.net: MAY 2020
A Jellyfish in the Eye
by Emanuele Siotto Pintor, MD, and Enrico Peiretti, MD
Emanuele Siotto Pintor, MD, and Enrico Peiretti, MD, share a case of a posttraumatic recurrent retinal detachment that resembles a jellyfish. Watch Now >
Diagonal Haptics Capture of Anterior Rhexis in Compromised Posterior Capsule
by Lukan Mishev, MD
Lukan Mishev, MD, describes a technique of diagonal fixation of plate haptic IOLs with or without four independent haptics. Watch Now >
Combining Mechanisms: Viscodilation, Trabeculectomy, and Hydrus Implantation
by Inder Paul Singh, MD
Inder Paul Singh, MD, describes combining various glaucoma procedures with complementary mechanisms of action to treat a patient with an IOP in the upper 30s and progressing moderate open-angle glaucoma. Watch Now >
DSAEK for Decompensated Penetrating Graft and ICE Syndrome
by Ozana Moraru, MD
Ozana Moraru, MD, demonstrates a Descemet stripping automated endothelial keratoplasty (DSAEK) pull technique on a pseudophakic eye with endothelial decompensation and iridocorneal endothelial (ICE) syndrome.
Watch Now >
[3D Video] Persistent Fetal Vasculature Syndrome
by Alexandre Grandinetti, MD, PhD
Alexandre Grandinetti, MD, PhD, describes a case of a 4-month-old girl with anterior and posterior manifestations of persistent fetal vasculature syndrome. Watch Now >
Stepwise Guide to Capsulorhexis in Intumescent Cataract
by Sourabh D. Patwardhan, MD
Sourabh D. Patwardhan, MD, demonstrates a five-step approach to performing the capsulorhexis in an eye with an intumescent cataract. Watch Now >
Other Series:
Informed Consent Telemedicine for Dry Eye Care
Presbyopia Unlocked Getting Comfortable With Advanced Presbyopia-Correcting Technologies
New Retina Radio COVID-19: Can Clinical Trials Proceed?
Clinical Minute MIGS for Severe and Refractory Glaucoma
follow us:
Get access to Eyetube''s video library Register Now ?
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to Eyeflash Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire TV! Add us to your address book: EyeWireMail@bmcenews.com
NEW EPISODE | April 22, 2020
WATCH THIS WEEK''S EPISODE
IN THIS EPISODE
BMC to Host First Virtual Spring Symposium in May
CMS Releases New Guidance on Restarting Elective Procedures
AAO Addresses Reopening of Ophthalmology Care
Ophthalmic Companies Devote Resources to Assist Eye Care Professionals and Patients During COVID-19
VIEW ALL SEGMENTS
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to EyewireTV Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
How was the IOL exchange performed?
Editorially independent content supported with advertising.
Managing a Torn and Dislocated IOL
One week after a patient received a secondary IOL, she reported blurry vision, and the IOL was found to be dislocated and torn. How did Beeran B. Meghpara, MD, handle the case?
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to Inside The Wills OR from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Get the latest information in Glaucoma Today.
THE TOP THREE ARTICLES YOU SHOULD BE READING:
1
Patient Pointers for Ocular Photography By John A. Hovanesian, MD, FACS
As the COVID-19 outbreak pushes ophthalmologists to conduct virtual consultations, patients' ability to capture anterior segment photographs with their smartphones has become important. Check out some tips to share with them.
2
The Role of Statins in Glaucoma Treatment
By Ahmad A. Aref, MD, MBA
Catch up on the evidence suggesting that these agents are protective.
3
Ten Tips for Graduating Glaucoma Fellows By
Michael Lin, MD; Ayan Chatterjee, MD, MSEd; Jonathan Chou, MD; Haben Kefella, MD; Stephen Moster, MD; Mary Qiu, MD; Aakriti Garg Shukla, MD; David Smits, MD; Swarup Swaminathan, MD; Astrid Werner, MD; and Cindy Zheng, MD
Get advice on your upcoming transition from attendings who started practice this past year.
SUPPLEMENT
Sponsored by Allergan
READ ON GlaucomaToday.COM ?
FEATURED VIDEO IN GLAUCOMA
Combining Mechanisms: Viscodilation, Trabeculectomy, and Hydrus Implantation
Inder Paul Singh, MD
WATCH NOW ON EYETUBE.NET
GLAUCOMA NEWS
05.18.20 AMA Issues Guidance to Physicians on Using COVID-19 Antibody TestsREAD MORE
05.18.20 EyePoint Pharmaceuticals Presents Data Showcasing Dexycu at the ASCRS Virtual MeetingREAD MORE
05.18.20 Sight Sciences Announces Positive Clinical Results From Trial Evaluating TearCare for the Treatment of Dry Eye DiseaseREAD MORE
RECENT Glaucoma Today ISSUES
stay updated on all things Glaucoma
click here
Advertise | Submit Breaking News | Contact Us
* Free print subscriptions are available to practicing physicians in the US.
All others, applicable subscription charges apply.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
You received this email because you are subscribed to Glaucoma Today Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us | Legal Disclaimer
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
TOP STORY OF THE WEEK Market Scope: Premium IOL Volume Faces Challenges in Rebounding Post-COVID
?
TRENDING NEWS 06.08.20
Novartis Provides Update On Use and Safety of Beovu (Brolucizumab)
?
06.12.20
Johnson & Johnson Vision Presents Myopia Research Findings at ARVO
?
06.11.20
US Hits 2 Million Coronavirus Cases As Many States See A Surge Of Patients
?
06.11.20 Modernizing Medicine Introduces Modmed SynapSYS Development Platform
?
06.09.20 Vasoptic Medical Receives FDA 510(k) Clearance for Retinal Imaging Device
?
06.09.20
Eversight Awarded Targeted Research Grant to Analyze COVID-19 Effects on Eye Donation
?
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire Today Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Celebrate progress and recognize the challenges.
NEW ISSUE | MAY 2020
The latest issue of CRST Europe celebrates the shrinking of the gender gap in ophthalmology and considers the challenges that remain.
READ MAY ISSUE
THE TOP THREE ARTICLES YOU SHOULD BE READING:
1
The Gender Gap By Lisa Brothers Arbisser, MD; Allon Barsam, MD, MA, FRCOphth; Bj?rn Johansson, MD, PhD, FEBO; A. John Kanellopoulos, MD; Aylin Kili?, MD; Marguerite B. McDonald, MD, FACS; Magda Rau, MD; Marie-Jos? Tassignon, MD, PhD, FEBO, FEBOS-CR; Denise M. Visco, MD, MBA
Get candid insight into progress toward gender equity in ophthalmology and hear from both genders how to influence further advances.
2
Cases That Have Stuck With Me By Allon Barsam, MD, MA, FRCOphth; Mark Kontos, MD; Soosan Jacob, MD, FRCS, DNB; Michael E. Snyder, MD; and Elizabeth Yeu, MD
Five ophthalmologists share memorable cases. What did they learn from those experiences?
3
Early Presbyopia in a Patient With High Hyperopia By Romesh Angunawela, BM, MD, FRCOphth, FRCS, Cert LRS; Gilles Lesieur, MD; Tal Raviv, MD; and Pavel Stodulka, MD, PhD
What are the surgical options for this patient who desires independence from spectacles and contact lenses?
Also in This Issue
Preoperative Corneal Marking for Toric IOL Implantation ?
Small Pupil, Dense Lens, Severe Zonulopathy ?
Graftless Corneal Endothelial Replacement ?
READ MAY ISSUE ?
FEATURED VIDEO IN
CATARACT
Diagonal Haptics Capture of Anterior Rhexis in Compromised Posterior Capsule Lukan Mishev, MD
WATCH NOW ON EYETUBE.NET
CATARACT & REFRACTIVE NEWS
05.22.20 A New Artificial Eye Mimics and May Outperform Human EyesREAD MORE
05.20.20 New Paper in Clinical and Experimental Optometry Summarizes SARS-CoV-2 Interaction With the Ocular SurfaceREAD MORE
05.19.20 Market Scope: Premium IOLs Expected to Drive Market Growth Over the Next 5 Years READ MORE
RECENT CRST Europe ISSUES
stay updated on all things Cataract
click here
Advertise | Submit Breaking News | Contact Us
* Free print subscriptions are available to practicing physicians in the US.
All others, applicable subscription charges apply.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
You received this email because you are subscribed to Cataract & Refractive Surgery Today Europe Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us | Legal Disclaimer
Can poor surgical visualization be improved?
Editorially independent content supported with advertising.
Macula-off Retinal Detachment After Cataract Surgery
A 49-year-old woman with a history of cataract surgery experienced a macula-off retinal detachment. Upon examination, a giant retinal tear and several other retinal breaks were evident. How did Michael N. Cohen, MD, handle the case?
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to Inside The Wills OR from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire TV! Add us to your address book: EyeWireMail@bmcenews.com
NEW EPISODE | April 29, 2020
WATCH THIS WEEK''S EPISODE
IN THIS EPISODE
AAO, ASCRS, and OOSS Develop Checklist for Reopening Ophthalmic Surgery Centers
Experts Discuss Impact of COVID-19 On Residents and Training Programs
Ocular Therapeutix Announces Phase 3 Data of Dextenza for Allergic Conjunctivitis
New Dates Announced for BMC Virtual Spring Symposium
VIEW ALL SEGMENTS
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to EyewireTV Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire TV! Add us to your address book: EyeWireMail@bmcenews.com
NEW EPISODE | May 20, 2020
WATCH THIS WEEK''S EPISODE
IN THIS EPISODE
Alcon ARGOS Biometer With Image Guidance Now Widely Available in the US
Johnson & Johnson Vision Announces US Launch of the Tecnis Multifocal Toric II IOL
Avellino''s ACTS Program to Help Protect Patients and Staff From COVID-19
Ocutrx Unveils OR-Bot Surgery Visualization Theatre
BVI Acquires Ophthalmic Viscoelastic Device Assets From Croma
VIEW ALL SEGMENTS
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to EyewireTV Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
TOP STORY OF THE WEEK Study: Dexamethasone Reduces Death In Hospitalized Patients With Severe Respiratory Complications of COVID-19 ?
TRENDING NEWS 06.15.20
Iveric Bio Announces Positive Zimura 18-Month Data Supporting the 12-Month Efficacy Findings for GA Secondary to AMD
?
06.19.20
Viela Bio Announces FDA Approval of Uplinza (Inebilizumab) for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)
?
06.15.20
FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine
?
06.19.20 Lineage Cell Therapeutics Reinitiates Patient Enrollment in Clinical Study of OpRegen for the Treatment of Dry AMD With GA
?
06.16.20 Bionic Sight Doses First Patient in a Phase 1/2 Clinical Trial of a New Investigational Treatment for Retinitis Pigmentosa
?
06.18.20
Santen and Orbis International Join Forces to Expand Access to Training for Eye Care Professionals Through Telemedicine Platform
?
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire Today Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Does COVID-19 affect the retina?
A small study published in The Lancet suggests that it does.
Tell me about the study.
Researchers used OCT to evaluate patients infected with SARS-CoV-2 to determine whether subclinical retinal changes were present. A total of 12 patients were examined 11 to 33 days after the onset of symptoms. All patients had normal blood parameters at the time of their eye exam.
What did they find?
All patients showed hyperreflective lesions at the level of ganglion cell and inner plexiform layers, more prominently at the papillomacular bundle in both eyes. Also of note, four patients presented with subtle cotton wool spots and microhemorrhages along the retinal arcade. The researchers noted that visual acuity and pupillary reflexes were normal in all eyes and that no symptoms or signs of intraocular inflammation were detected.
The take home:
The study authors stated that although COVID-19 animal models suggest that ocular lesions could include retinitis and optic neuritis, this is, to the best of their knowledge, the first report of retinal findings possibly associated with COVID-19 infection in humans.
Advertisement:
WHAT YOUR PATIENT MIGHT ASK YOU
Are there any glasses that can prevent my myopia from getting worse? There''s a new option-if you live in the European Union (EU). SightGlass Vision received approval to commercialize its new product in the EU, United Kingdom, and other European Economic Area countries.
What is the new product?
It''s a spectacle lens made with the company's Diffusion Optics Technology and is designed to lower contrast in a focus-independent manner while still providing excellent visual acuity. This works under the hypothesis that high retinal contrast causes myopia and therefore lowering retinal contrast would reduce the progression of myopia.
When can we get it in the United States?
TBD.
IN OTHER NEWS
Optometry practices looted. After weeks of being closed down due to COVID-19, most optometry practices had finally started to reopen by the end of May. Unfortunately, many practices in several cities across the nation, already feeling a sense of hardship, were looted during protests over the death of George Floyd. ODs on Facebook organized a GoFundMe fundraiser to raise money for OD-owned independent practices damaged by looters during the protests. Donate if you can. Share if you're willing.
Black lives matter. Of course there's a bigger issue outside of the looting, and it's part of the reason for the protests: racism. Below are some organizations you can support that serve the black community.
. The NAACP Legal Defense and Educational Fund: America's premier legal organization fighting for racial justice through litigation, advocacy, and public education.
. Advancement Project: A multi-racial civil rights organization that uses innovative tools and strategies to strengthen social movements and achieve high impact policy change.
SOCIAL MEDIA ROUNDUP
89% The number of practices surveyed that now incorporate telehealth care. (via)
You''re not the only one with money problems.
Vision Group Holdings, the management company behind TLC and Lasik Vision Institute, has filed for bankruptcy. (via)
Enjoy this email? Tell your friends to sign up here!
Have news or a comment to share?
send me an email!
Copyright ? 2020 2020glance.com, All rights reserved.
Email Me // About
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to 20/20 Glance Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire TV! Add us to your address book: EyeWireMail@bmcenews.com
NEW EPISODE | July 1, 2020
WATCH THIS WEEK''S EPISODE
IN THIS EPISODE
The FDA Does Not Approve AbbVie's Wet AMD Drug Candidate Abicipar Pegol
Eye Care Experts Participate In the First AECOS Virtual Summer Symposium
Executives Discuss Impact of COVID-19 on Ophthalmic Industry
Novartis Withdraws Marketing Application of Dry Eye Drug Xiidra in Europe
VIEW ALL SEGMENTS
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to EyewireTV Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Register today for a LIVE Webinar Series Featuring Hot Topics and Interactive Discussion from AECOS Europe.
Jorge Alio, MD| Neural Network AI to Guide Treatment of Keratoconus by ICRS
Refractive Revival: What Patients Need and Want Post COVID-19
Moderator: Erik Mertens MD
Discussants: Gerd Auffarth MD, Francesco Carones MD, Matt Jensen, Shareef Mahdavi
Topics:
Dan Reinstein, MD | What worries me...
Stefanie Schmickler, MD | What worries me...
Amanda Carones | How do we bounce back?
AECOS Ophthalmic Innovation Forum
Saturday, August 1 | 10:00 AM - 12:00 PM Central Daylight Time
Moderator: William Link PhD
Faculty: Andy Corley, Richard Lindstrom MD
Companies:
Intelon | Richard Lindstrom MD
LENSAR GEN 2 | Nick Curtis
AcuFocus | Yari Mitchell
RxSight | Ron Kurtz MD
Equinox | Matt Larson
TearClear | Robert Dempsey
Tarsus Rx | Bobak Azamian MD
Oyster Point Pharma | Jeffrey Nau PhD
Register Today!
View email in your browser
This sponsored message helps support the free educational content produced by Bryn Mawr Communications LLC.
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania19087 | United States
You received this email because you are subscribed to BMC Group from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
FEATURED NEWS STORY Forecasting the New Normal: Experts Across Eye Care Discuss COVID-19's Impact On a recent episode of Ophthalmology Off the Grid, cohosts Gary W?rtz, MD, and Blake Williamson, MD, MPH, were joined by Iqbal Ike K. Ahmed, MD, FRCSC; John Kitchens, MD; and Justin Schweitzer, OD, to discuss COVID-19's impact across eye care and share their predictions for how the current situation will alter the future of their areas of expertise. VIEW STORY ?
OTHER COVID-19 NEWS 04.23.20 FDA Authorizes First Test for Patient At-Home Sample Collection
The FDA has authorized the first diagnostic test with a home collection option for COVID-19. LabCorp's COVID-19 RT-PCR test allows testing of samples self-collected by patients at home using the company''s Pixel COVID-19 home collection kit. VIEW STORY ?
04.23.20 How Meeting Cancellations Have Affected the Optometric Profession and Industry
On a recent episode of The MOD Pod, Jessilin Quint, OD, FAAO, and Frank Won, OD, speak with Jason R. Miller, OD, FAAO; Emilie Seitz; and Walter O. Whitley, OD FAAO, about how meeting cancellations have affected the optometric profession, how ODs are fulfilling their CE credit requirements, and how optometry students are coping with distance learning. VIEW STORY ?
VIEW ALL COVID-19 COVERAGE
This resource has been made possible with support from our industry sponsors
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire News COVID-19 from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
What impact are these procedures having on patient care?
NEW ISSUE | May/June 2020
This issue of Glaucoma Today describes the impact that MIGS is having on the field.
READ May/June
ISSUE
THE TOP THREE ARTICLES YOU SHOULD BE READING:
1
Memorable MIGS Cases By
Won I. Kim, MD; Mazeyar Saboori, MD; Monisha M. Vora, MD; H. George Tanaka, MD; Bac T. Nguyen, MD; I. Paul Singh, MD; and Lorraine M. Provencher, MD
Explore the value of microinvasive glaucoma surgery through scenarios presented by several surgeons.
2
Highlights of the 2020 AGS Annual Meeting
By Geoffrey T. Emerick, MD
Catch up on the results from clinical trials and research studies that were presented at the 30th annual meeting of the American Glaucoma Society this spring.
3
Pearls and Practices for Virtual Eye Care By
Sophie D. Liao, MD; Eimi Rodriguez-Cruz, BS; Malik Y. Kahook, MD; and Cara E. Capitena Young, MD
Get nine tips on how to harness virtual health to deliver the care your patients need.
Also in This Issue
Eye Care in the Era of COVID-19 ?
Crowdsourcing in Ophthalmology ?
Company Culture: The Secret Sauce for Success ?
READ May/June ISSUE ?
FEATURED VIDEO IN GLAUCOMA
Chronic Hypotony Complicated With Filtration Bleb Rupture
Frederic Aissani, MD
WATCH NOW ON EYETUBE.NET
GLAUCOMA NEWS
06.19.20 Providers to Congress: Patients Will Lose Access to Care Without Permanent Expansion of TelehealthREAD MORE
06.18.20 Federation of American Hospitals Demands More Time for Providers to Repay Advance Medicare Payments Due SoonREAD MORE
06.16.20 Study: Dexamethasone Reduces Death in Hospitalized Patients With Severe Respiratory Complications of COVID-19READ MORE
RECENT Glaucoma Today ISSUES
stay updated on all things Glaucoma
click here
Advertise | Submit Breaking News | Contact Us
* Free print subscriptions are available to practicing physicians in the US.
All others, applicable subscription charges apply.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
You received this email because you are subscribed to Glaucoma Today Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us | Legal Disclaimer
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
FEATURED NEWS STORY New Dates Announced for BMC Virtual Spring Symposium Bryn Mawr Communications (BMC) has announced that its first virtual educational initiative, the BMC Virtual Spring Symposium, will now be held on May 29-30. The BMC Virtual Spring Symposium is designed to enable discussion, engagement, and live Q&A for members of the vision community while the traditional meeting schedule remains compromised due to COVID-19. VIEW STORY ?
OTHER COVID-19 NEWS 04.24.20 How Will the COVID-19 Crisis Transform Retina Care in Europe
With Jordi Mon?s, MD, PhD (Spain) at the helm, New Retina Radio asks David H.W. Steel, MBBS, FRCOphth (United Kingdom); Murat Oncel, MD (Turkey); and Armin Wolf, MD, FEBO (Germany), how the COVID-19 crisis will transform retina care in Europe? VIEW STORY ?
04.27.20 CMS Reevaluates Accelerated Payment Program and Suspends Advance Payment Program
CMS will not be accepting any new applications for the Advance Payment Program, and will be reevaluating all pending and new applications for Accelerated Payments in light of historical direct payments made available through the Department of Health & Human Services' (HHS) Provider Relief Fund. VIEW STORY ?
VIEW ALL COVID-19 COVERAGE
This resource has been made possible with support from our industry sponsors
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire News COVID-19 from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
FEATURED NEWS STORY Market Scope: Premium IOL Volume Faces Challenges in Rebounding Post-COVID
Results from Part 1 of Market Scope's "COVID-19 US Practice Impact Survey" reveal that nearly 41 percent of surgeons expect a decrease in premium IOL conversion once COVID-19 subsides. These surgeons expect an average decrease of 34 percent, and most respondents believe that financial concerns would be the primary driver of this decrease. VIEW STORY ?
OTHER COVID-19 NEWS 06.081.20
Phosphorus Announces FDA Approval Of At-Home Saliva Test for COVID-19
Phosphorus announced that the FDA granted the Emergency Use Authorization request for its saliva test for COVID-19 that features at-home sample collection. The test is available by ordering online, as well as through health care and employer partnerships aimed at safely resuming operations. This is only the second at-home unsupervised saliva test approved so far by the FDA. VIEW STORY ?
06.08.20 New York Times: Hospitals Got Bailouts and Furloughed Thousands While Paying CEOs Millions
The New York Times analyzed tax and securities filings by 60 of the country's largest hospital chains, which have received a total of more than $15 billion in emergency funds through the economic stimulus package in the federal CARES Act. The hospitals are collectively sitting on tens of billions of dollars of cash reserves that are supposed to help them weather an unanticipated storm. VIEW STORY ?
VIEW ALL COVID-19 COVERAGE
This resource has been made possible with support from our industry sponsors
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire News COVID-19 from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire TV! Add us to your address book: EyeWireMail@bmcenews.com
NEW EPISODE | May 6, 2020
WATCH THIS WEEK''S EPISODE
IN THIS EPISODE
AAO Surveys Reveal the Effect COVID-19 is Having On Ophthalmology Practices
Leaders of Ophthalmic Medical Societies Provide Updates on Annual Meetings
The FDA Issues an Emergency Use Authorization For Potential COVID-19 Treatment
Kala Pharmaceuticals Resubmits NDA For Dry Eye Drug Candidate Eysuvis
VIEW ALL SEGMENTS
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to EyewireTV Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire TV! Add us to your address book: EyeWireMail@bmcenews.com
NEW EPISODE | May 13, 2020
WATCH THIS WEEK''S EPISODE
IN THIS EPISODE
COVID-19 Analysis: Ophthalmology Lost More Patient Volume Than Any Other Specialty
FDA Approves Quidel's Sofia 2, First Antigen Test to Help in the Detection of COVID-19
AbbVie Completes $63 Billion Acquisition of Allergan
Sight Sciences Introduces the Next-Generation Omni Surgical System for MIGS
Oyster Point Announces Phase 3 Trial Results of Nasal Spray for Dry Eye Disease
VIEW ALL SEGMENTS
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to EyewireTV Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
FEATURED NEWS STORY AAO Calls on Health Plans to Suspend Prior Authorization and Step Therapy
The American Academy of Ophthalmology this week published an open letter to all health plans, calling for the suspension of regulatory barriers, specifically prior authorization and step therapy, for both COVID-19 and non-COVID-19-related services until the health care delivery system returns to normalcy. VIEW STORY ?
OTHER COVID-19 NEWS 05.13.20 ASRS Announces Virtual Annual Scientific Meeting July 24-26, 2020
Due to the COVID-19 pandemic, the American Society of Retina Specialists (ASRS) has decided to hold its annual meeting online. In a letter to membership, Timothy Murray, MD, MBA, ASRS President, and Philip Ferrone, MD, Program Chair, said the live streaming portion of this event will start the evening of Friday, July 24 and end the afternoon of Sunday, July 26. VIEW STORY ?
05.14.20 What Technologies Will Endure After the COVID-19 Pandemic Subsides? New Retina Radio host John Kitchens, MD, is joined by Caroline Baumal, MD; Mar?a Berrocal, MD; and Judy Kim, MD, to discuss which practices will be rolled into modern protocols, which technologies on the horizon may have greater value in a post-COVID world, and how treatment decisions have (or have not) been adjusted to face today's unique challenges. VIEW STORY ?
VIEW ALL COVID-19 COVERAGE
This resource has been made possible with support from our industry sponsors
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire News COVID-19 from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Can telehealth work for dry eye patients?
Editorially Independent Podcast, Supported With Advertising
Telemedicine for Dry Eye Care
Ranya Habash, MD; and William Trattler, MD, join Marguerite McDonald, MD, FACS, to discuss using telemedicine for dry eye patients.
LISTEN NOW
Listen to Recent Episodes
Episode 28
Providing Patients With Customized Care
Episode 27
The Growing Femtosecond Market
How to Listen
Subscribe on Apple or Android to have each new episode automatically downloaded to your device, stream each episode on-demand on Eyetube, or use any podcast manager.
Subscribe to Informed Consent:
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to Informed Consent from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
FEATURED NEWS STORY Insight Into FDA's Revised Policy on Antibody Tests: Prioritizing Access and Accuracy
In a blog post on the FDA website, agency leaders outlined a new policy that aims to provide more oversight of COVID-19 antibody tests. The revised policy on antibody tests was written by Anand Shah, MD, Deputy Commissioner for Medical and Scientific Affairs, and Jeff Shuren, MD, Director, Center for Devices and Radiological Health. VIEW STORY ?
OTHER COVID-19 NEWS 05.06.20 Experts Discuss Telemedicine's Viability and Durability During COVID-19
New Retina Radio host John Kitchens, MD, talks with S.K. Steven Houston III, MD; John B. Miller, MD; and Ehsan Rahimy, MD, to understand telemedicine's viability and durability during and beyond the COVID-19 era, and to review proper coding tactics to ensure compliance. VIEW STORY ?
05.07.20 CooperVision Offers Complimentary Contact Lenses for Hospital Workers on Front Lines of COVID-19 Pandemic
In support of essential hospital workers fighting on the front lines of the COVID-19 pandemic, CooperVision said it will provide US eye care professionals with complimentary contact lens refills. Through the program, essential hospital workers may receive one box of CooperVision contact lenses for each eye, including all 1-day, 2-week, and monthly brands that the company manufactures. VIEW STORY ?
VIEW ALL COVID-19 COVERAGE
This resource has been made possible with support from our industry sponsors
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire News COVID-19 from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
FEATURED NEWS STORY FDA Approves Quidel's Sofia 2, First Antigen Test to Help in the Rapid Detection of COVID-19
Quidel, maker of diagnostic tests for a variety of conditions including acute conjunctivitis and dry eye disease, announced that it has received Emergency Use Authorization (EUA) from the FDA to market its Sofia 2 SARS Antigen FIA, a rapid point-of-care test for the detection of COVID-19. Sofia 2 is the first antigen test approved by the FDA, a new category of tests for use in the ongoing pandemic. VIEW STORY ?
OTHER COVID-19 NEWS 05.11.20 Analysis: Ophthalmology Lost More Patient Volume Due to COVID-19 Than Any Other Specialty
The analysis of over 2 million patient visits and encounters from 228 hospitals in 40 states by Strata Decision Technology showed that ophthalmology lost 81% of patient volume year-over-year when comparing 2-week volumes in March and April 2020 vs the same period in 2019. During the same period, it also found a 97% reduction in cataract surgery volume-the largest reduction of any surgical procedure-and an 88% reduction in glaucoma procedures. VIEW STORY ?
05.08.20 Retina-Focused Societies Around the World Provide Guidance to Their Members
New Retina Radio special guest host and president of the Retina World Congress Tarek Hassan, MD (United States), sits down with Asia-Pacific VitreoRetina Society leadership member Paisan Ruamviboonsuk, MD (Thailand), and Pan-American Association of Ophthalmology Immediate Past-President J. Fernando Arevalo, MD, PhD (United States), and Euretina General Secretary Anat Loewenstein, MD (Israel). VIEW STORY ?
VIEW ALL COVID-19 COVERAGE
This resource has been made possible with support from our industry sponsors
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire News COVID-19 from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
TOP STORY OF THE WEEK Can Ophthalmic Clinical Trials Proceed During COVID-19 Crisis? ?
TRENDING NEWS 04.27.20 CMS Reevaluates Accelerated Payment Program and Suspends Advance Payment Program
?
05.01.20
Gilead 'Moving Very Quickly' With FDA on Possible Coronavirus Use, CEO Says
?
04.30.20 Quest, LabCorp Launch Nationwide COVID-19 Antibody Testing in Pharmacies and Online
?
04.27.20 New Dates Announced for BMC Virtual Spring Symposium
?
04.29.20 COVID-19: Finding Opportunity in Crisis
?
04.28.20 Sanofi/Regeneron and Roche Report Mixed Results for Potential COVID-19 Treatments
?
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire Today Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Get the 3-month results.
Editorially independent content supported with advertising.
Clinical Trial Data on a Fixed Combination of Netarsudil and Latanoprost
Ehsan Sadri, MD, and Neda Shamie, MD, discuss 3-month data from a randomized, double-masked, phase 3 clinical trial of a fixed combination of netarsudil and latanoprost. How did the fixed combination stack up against monotherapy with netarsudil or latanoprost?
CLICK HERE TO WATCH THE VIDEO
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to Clinical Minute from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Register today for a LIVE Webinar Series Featuring Hot Topics and Interactive Discussion from AECOS America and AECOS Europe.
Thursday, June 25 | 7:00 - 8:30 PM Central Daylight Time
Practice Impossible
AECOS Industry Panel
Thursday, July 9 | 7:00 - 8:30 PM Central Daylight Time
AECOS Clinical Case Presentations
Medical Legal issues
AECOS Europe Series
Saturday, July 18 | 16:00 - 18:00 Central European Time | (9:00 - 11:00 AM Central Daylight Time)
Artificial Intelligence
Presbyopia
Saturday, July 25 | 16:00 - 18:00 Central European Time | (9:00 - 11:00 AM Central Daylight Time)
Breaking News
Refractive Revival: What Patients Need and Want Post COVID-19
AECOS Ophthalmic Innovation Forum
Saturday, August 1 | 10:00 AM - 12:00 PM Central Daylight Time
Register Today!
View email in your browser
This sponsored message helps support the free educational content produced by Bryn Mawr Communications LLC.
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania19087 | United States
You received this email because you are subscribed to Bio-Tissue from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
TOP STORY OF THE WEEK Survey: Use of Virtual Education Soars; Telemedicine Remains a Small Percentage of Volume ?
TRENDING NEWS 06.26.20
The FDA Does Not Approve Allergan's Wet AMD Drug Candidate Abicipar Pegol
?
06.22.20
Johnson & Johnson Vision Receives FDA Clearance for Catalys cOS 6.0 Software for Astigmatism Management
?
06.26.20
2021 ASCRS Annual Meeting Pushed Back to August
?
06.25.20 Topcon Announces the European Launch of MYAH Management Tool for Myopia and Dry Eye
?
06.26.20 DORC Launches New Range of EVA EquiPhaco Needles and Sleeves
?
06.25.20
Visual Clinic's Patient Flow Management Solution Aims to Help Eye Care Clinics Operate Post-COVID-19 ?
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire Today Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Get your best Mirante image published in Retina Today!
Grand Prix submission will be featured on Retina Today published by BMC Vision. Get your imaging expertise published in the RT journal!
Submission Deadline:August 20th, 2020
If you have any questions, please feel free to contact NIDEK at marketing@nidek.co.jp
Scanning Laser Ophthalmoscope Mirante
The Ultimate Multimodal Imaging Platform
NOTE: The availability of the products differs from country to country depending on the status of approval in each country. Please contact our distributor in your country for the precise information.>>Distributor Search
Specifications and design are subject to change without notice.
This sponsored message helps support the free educational content produced by Bryn Mawr Communications LLC.
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania19087 | United States
You received this email because you are subscribed to Nidek from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
How do you convey their value to patients?
Editorially Independent Podcast, Supported With Advertising
The Value of Laser Cataract Surgery and Toric IOLs
Kendall Donaldson, MD, MS; Preeya Gupta, MD; and Marguerite McDonald, MD, FACS, tackle how to explain the value of laser cataract surgery and toric IOLs to patients who have astigmatism.
LISTEN NOW
Listen to Recent Episodes
Episode 29
Telemedicine for Dry Eye Care
Episode 28
Providing Patients With Customized Care
How to Listen
Subscribe on Apple or Android to have each new episode automatically downloaded to your device, stream each episode on-demand on Eyetube, or use any podcast manager.
Subscribe to Informed Consent:
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to Informed Consent from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
TOP STORY OF THE WEEK CMS Releases Guidance for How Health Systems Can Restart Elective Procedures ?
TRENDING NEWS 04.17.20 Forecasting the New Normal: Experts Across Eye Care Discuss COVID-19's Impact
?
04.16.20 COVID-19: The Impact on Training Programs
?
04.14.20 Ambulatory Surgery Centers Eligible For New Relief Grant Funds
?
04.17.20 FDA Authorizes First Test for Patient At-Home Sample Collection
?
04.17.20 COVID-19: Fellowship and Training in Flux
?
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire Today Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Find out what it is about the LENSAR? Laser that helps Dr. Rostov deliver the best possible outcomes to each and every patient.
From seamless transfer of pre-op diagnostics to IntelliAxis Refractive Capsulorhexis?, the LENSAR? Laser provides Audrey Talley Rostov, MD, with tools for confident axis placement and accurate toric IOL alignment.
Watch the video ?
A Necessity for All Advanced IOL Procedures
Dr. Rostov shares why the LENSAR Laser System should be part of any advanced IOL procedure.
Watch the video
Making Complex Cases Routine
Even in the most complex cases, the LENSAR Laser guides Dr. Rostov to deliver the best possible outcomes for all of her cataract patients.
Watch the video
See what other leading experts are saying about LENSAR's evolved advantages.
View All Videos ?
? 2020 LENSAR, Inc. All rights reserved. LENSAR, the LENSAR logo, the LENSAR Cataract Laser With Augmented Reality logo, and IntelliAxis Refractive Capsulorhexis are registered trademarks of LENSAR, Inc. 50-00276-000 Rev A 03/20
View email in your browser
This sponsored message helps support the free educational content produced by Bryn Mawr Communications LLC.
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania19087 | United States
You received this email because you are subscribed to Lensar from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Advances in OCT technology can help you accurately diagnose suspected glaucoma.
"The DRI OCT Triton (Topcon) is equipped with the Active Eye Tracking feature for use during angiography...the device is capable of 100,000 A-scans/sec-more than double that of SD-OCT-which reduces the impact of microsaccades."
Ki Ho Park, MD, PhD
In this insert, Ki Ho Park, MD, PhD, discusses common operator and clinician errors that can lead to misinterpretation of OCT images used to evaluate patients with suspected glaucoma. He reviews how the use of the swept-source OCT (SS-OCT) DRI OCT Triton (Topcon) complements his evaluations and combats some of those errors. He also emphasizes how swept-source technology improves the ability to diagnose glaucoma compared to spectral-domain (SD-OCT) technology.
read Insert
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to Supplements from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
FEATURED NEWS STORY FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine
The FDA revoked the emergency use authorization (EUA) that allowed for chloroquine and hydroxychloroquine to be used to treat certain hospitalized patients with COVID-19. Based on its ongoing analysis of the EUA and emerging scientific data, the FDA determined that chloroquine and hydroxychloroquine are "unlikely to be effective in treating COVID-19 for the authorized uses in the EUA." VIEW STORY ?
OTHER COVID-19 NEWS 06.15.20
Orbis International Launches Virtual Flying Eye Hospital Training Programs
Orbis International launched virtual Flying Eye Hospital training programs through its telemedicine platform, Cybersight, which provides online training and mentorship for eye care professionals in low- and middle-income countries. The inaugural program has been designed for eye care professionals in Zambia who were due to receive in-person training on board the Flying Eye Hospital last month. VIEW STORY ?
06.15.20 AstraZeneca to Supply Europe Up to 400 Million COVID-19 Vaccine Doses
AstraZeneca announced that it has reached an agreement with Europe's Inclusive Vaccines Alliance (IVA) to supply up to 400 million doses of the University of Oxford's COVID-19 experimental vaccine, with deliveries starting by the end of this year. VIEW STORY ?
VIEW ALL COVID-19 COVERAGE
This resource has been made possible with support from our industry sponsors
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire News COVID-19 from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
TOP STORY OF THE WEEK Novartis Withdraws Marketing Application of Dry Eye Drug Xiidra in Europe
?
TRENDING NEWS 06.30.20
Iveric bio Announces First Patient Dosed in Second Zimura Phase 3 Trial for Treatment of GA
?
07.02.20
Quantel Medical Completes Acquisition of Ellex
?
06.30.20
After Sale of Ellex Medical Lasers, Nova Eye Medical is Formed
?
06.30.20 Samsung Bioepis Initiates Phase 3 Clinical Trial for SB15, Proposed Biosimilar to Eylea (Aflibercept)
?
06.29.20 Coburn Technologies Announces the New Velocity LTE Spin Coating System
?
06.30.20
OcuBlink Introduces Synthetic Eyeballs for AR/VR Testing
?
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire Today Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
What most affected patients' satisfaction?
Editorially independent content supported with advertising.
Satisfaction After Refractive Lens Exchange Using an Extended Depth of Focus IOL
Steven Schallhorn, MD, joins Neda Shamie, MD, to discuss a 3-month study of postoperative satisfaction with refractive lens exchange using an extended depth of focus IOL. Which independent factors were predictive of patients' satisfaction?
CLICK HERE TO WATCH THE VIDEO
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to Clinical Minute from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don't miss the top videos of the month on Eyetube.net!
What''s New to Eyetube.net: June 2020
Aerosol During Phacoemulsification: How to Make Cataract Surgery Safe During COVID-19
by Asaf Achiron, MD; Derek Tole, MD; Duncan Leadbetter, MD; Johan Keller, MD; Kieren Darcy, MD; Omar El-Haddad, MD; and Sidath Liyanage, MD
Asaf Achiron, MD, and colleagues conduct a series of experiments investigating aerosol production during cataract surgery. Get some helpful tips on reducing potential risk during the COVID-19 pandemic. Watch Now >
Traumatic Iridodialysis and Cyclodialysis Repair in a Phakic Child
by Ahmed Sallam, MD; Brita Rook, MD; and Riley Sanders, MD
Ahmed Sallam, MD; Brita Rook, MD; and Riley Sanders, MD, present a case of a young patient with traumatic iridodialysis and cyclodialysis as well as worsening hyopotony maculopathy. How did they approach surgical repair while preserving the crystalline lens? Watch Now >
An Update on My Modifications of the Yamane Technique: a Stepwise Approach
by D. Brian Kim, MD
D. Brian Kim, MD, describes how he has modified the Yamane technique to make it easier and more reliable and provide better outcomes. Watch Now >
Aleksandra Rachitskaya, MD, demonstrates the scleral fixation of a secondary IOL using an MX60 enVista lens (Bausch + Lomb) and Gore-Tex sutures.
Watch Now >
Chronic Hypotony Complicated With Filtration Bleb Rupture
by Frederic Aissani, MD
Frederic Aissani, MD, describes how he managed the case of a 62-year-old patient who experienced chronic hypotony 5 years after undergoing a nonpenetrating deep sclerectomy. Watch Now >
Other Series:
Ophthalmology off the Grid Survive & Thrive: The Transition to Practice
Informed Consent The Value of Laser Cataract Surgery and Toric IOLs
Clinical Minute Outcomes With EDOF IOLs After Laser Refractive Surgery
MIGS Unplugged Educating the Next Generation of Surgeons
follow us:
Get access to Eyetube''s video library Register Now ?
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to Eyeflash Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
How do you explain their benefits to patients?
Editorially Independent Podcast, Supported With Advertising
The Benefits of Premium-Channel IOLs
William Wiley, MD; Brandon Ayres, MD; and John Berdahl, MD, join Marguerite McDonald, MD, FACS, to share how they explain the benefits of premium-channel IOLs to patients.
LISTEN NOW
Listen to Recent Episodes
Episode 30
The Value of Laser Cataract Surgery and Toric IOLs
Episode 29
Telemedicine for Dry Eye Care
How to Listen
Subscribe on Apple or Android to have each new episode automatically downloaded to your device, stream each episode on-demand on Eyetube, or use any podcast manager.
Subscribe to Informed Consent
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to Informed Consent from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire TV! Add us to your address book: EyeWireMail@bmcenews.com
BVI Launches CryoTreq for Treatment of Retinal Tears and Detachments
Bausch + Lomb Receives FDA Clearance for Infuse Daily Silicone Hydrogel Contact Lenses
VIEW ALL SEGMENTS
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to EyewireTV Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
FEATURED NEWS STORY CMS Reveals Number of People Who Signed Up for Coverage on HealthCare.gov During COVID-19
The Centers for Medicare & Medicaid Services (CMS) released a trends report that provides data on the number of individuals who signed up for coverage on HealthCare.gov through a special enrollment period (SEP) during the COVID-19 pandemic. VIEW STORY ?
OTHER COVID-19 NEWS 06.30.20
Remdesivir, the First Coronavirus Drug, Gets a Price Tag
Remdesivir, the first drug shown to be effective against the coronavirus, will be distributed under an unusual agreement with the federal government that establishes nonnegotiable prices and prioritizes American patients, health officials announced on Monday. VIEW STORY ?
06.30.20 Hospitals in New COVID-19 Hot Spots Face Delicate Balancing Act With Elective Surgeries
Some hospital systems located in states that are seeing huge spikes of COVID-19 are continuing to perform elective procedures and developing strategies to avoid a total shutdown. VIEW STORY ?
VIEW ALL COVID-19 COVERAGE
This resource has been made possible with support from our industry sponsors
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. If you have any questions, please submit using our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania 19087 | United States
You received this email because you are subscribed to Eyewire News COVID-19 from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire TV! Add us to your address book: EyeWireMail@bmcenews.com
NEW EPISODE | June 3, 2020
WATCH THIS WEEK''S EPISODE
IN THIS EPISODE
BMC Virtual Spring Symposium Brings Unique Perspective to Eye Care Community
Bausch + Lomb Announces European Launch of a New Platform of Preloaded IOLs
SightGlass Vision Granted CE Mark for Eyeglasses That Slow Myopia Progression in Children
In-Person ESCRS and Euretina Meetings Cancelled; Virtual Meetings Planned
VIEW ALL SEGMENTS
Advertise | Send a Tip or Event | Contact Us
All Rights Reserved. Reproduction in whole or in part without permission is strictly prohibited.
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne,
Pennsylvania
19087 |
United States
You received this email because you are subscribed to EyewireTV Newsletter from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
A preview of new nomograms, novel algorithms, and future outlooks.
Meeting Coverage From the 2020 AAO Virtual Cornea Subspecialty Day
Speakers from the meeting highlight key points of their presentations.
The Future of Limbal Stem Cell Transplantation
In her review of limbal stem cell transplantation techniques and surgical outcomes, Ashiyana Nariani, MD, MPH, highlights recent scientific work aiming to address some of the issues associated with current standards of care. Among the advances are several modified versions of simple limbal epithelial transplantation and xenofree alternatives for culturing limbal epithelial stem cells.
Predicting Graft Survival After PKP
Eric J. Shiuey, MS, reports on the use of a novel nomogram to predict graft survival after penetrating keratoplasty (PKP) and shares the top six variables with significant predictability of graft failure. Mr. Shiuey and colleagues at Wills Eye Hospital in Philadelphia conducted a study of more than 1,000 corneal transplants performed since 2007.
A Deep-Learning Neural Network for Diagnosing Corneal Diseases
Use of a multi-disease, deep-learning neural network algorithm can simplify the diagnosis of common corneal diseases, Mohamed Abou Shousha, MD, FRCS, PhD, reports. He and researchers from Bascom Palmer Eye Institute in Miami developed a device to autonomously diagnose dry eye disease, keratoconus, and Fuchs endothelial dystrophy. In an independent validation study, their AI algorithm successfully classified 100% of Fuchs endothelial dystrophy, 97% of keratoconus, 90% of dry eye disease, and 92% of healthy eyes.
These programs are not affiliated with the official program of AAO 2020
View email in your browser
Please do not reply to this email. Replies are routed to an unmonitored mailbox. In order to contact us please use our contact form.
Bryn Mawr Communications LLC | 1008 Upper Gulph Road | Wayne, Pennsylvania19087 | United States
You received this email because you are subscribed to Eyetube Meeting Coverage from Bryn Mawr Communications LLC. Manage Preferences | Unsubscribe | Contact Us
Don''t miss an Eyewire News Update! Add us to your address book: EyeWireMail@bmcenews.com
FEATURED NEWS STORY Regeneron Advances Double Antibody Cocktail Into Phase 3 COVID-19 Prevention Study
Regeneron Pharmaceuticals announced the start of a phase 3 study investigating the ability of the double antibody cocktail REGN-COV2 to prevent infection among uninfected people who have had close exposure to a COVID-19 patient. VIEW STORY ?
OTHER COVID-19 NEWS 07.06.20
OraSure Technologies' Spit Test for COVID-19 is Coming Closer
A Pennsylvania technology company is racing to "democratize" testing for COVID-19, according to a Philadelphia Inquirer report. By September, Bethlehem's OraSure Technologies hopes to have a rapid, oral-fluid self-test on the market, one as quick and simple to use as those that can detect pregnancies. VIEW STORY ?
07.06.20 Gilead's Veklury Gains Conditional EU Approval for Treatment of COVID-19
The European Commission granted conditional approval to Gilead Science''s Veklury (remdesivir) for the treatment of SARS-CoV-2 infection. The approval was supported by results from the ACTT trial, led by the US National Institute of Allergy and Infectious Diseases. VIEW STORY ?
VIEW ALL COVID-19 COVERAGE
This resource has been made possible with support from our industry sponsors
